Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.

2.50
Hdl Handle:
http://hdl.handle.net/10541/108797
Title:
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.
Authors:
Taylor, P M; O'Driscoll, B R; Gattamaneni, Rao; Woodcock, A A
Abstract:
Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern.
Affiliation:
Department of Diagnostic Radiology, University of Manchester.
Citation:
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features. 1991, 44 (5):299-301 Clin Radiol
Journal:
Clinical Radiology
Issue Date:
Nov-1991
URI:
http://hdl.handle.net/10541/108797
DOI:
10.1016/S0009-9260(05)81262-0
PubMed ID:
1760904
Type:
Article
Language:
en
ISSN:
0009-9260
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTaylor, P Men
dc.contributor.authorO'Driscoll, B Ren
dc.contributor.authorGattamaneni, Raoen
dc.contributor.authorWoodcock, A Aen
dc.date.accessioned2010-08-02T09:50:43Z-
dc.date.available2010-08-02T09:50:43Z-
dc.date.issued1991-11-
dc.identifier.citationChronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features. 1991, 44 (5):299-301 Clin Radiolen
dc.identifier.issn0009-9260-
dc.identifier.pmid1760904-
dc.identifier.doi10.1016/S0009-9260(05)81262-0-
dc.identifier.urihttp://hdl.handle.net/10541/108797-
dc.description.abstractCarmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern.en
dc.language.isoenen
dc.subjectCentral Nervous System Canceren
dc.subject.meshCarmustine-
dc.subject.meshCentral Nervous System Neoplasms-
dc.subject.meshChild-
dc.subject.meshHumans-
dc.subject.meshPulmonary Fibrosis-
dc.subject.meshTime Factors-
dc.subject.meshTomography, X-Ray Computed-
dc.titleChronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.en
dc.typeArticleen
dc.contributor.departmentDepartment of Diagnostic Radiology, University of Manchester.en
dc.identifier.journalClinical Radiologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.